CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 27, 2014--
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the fields of
cancer metabolism and inborn errors of metabolism, today announced that
the company will host a conference call and live audio webcast on
Thursday, March 6, 2014, at 8:30 a.m. EST to report its fourth quarter
and full year 2013 financial results and discuss recent business
activities.
In order to participate in the conference call, please dial
1-877-377-7098 (domestic) or 1-631- 291-4547 (international) and refer
to conference ID 4988636. The live webcast can be accessed under "Events
& Presentations" in the Investors and Media section of the company's
website at www.agios.com.
The archived webcast will be available on the company's website
beginning approximately two hours after the event.
About Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals is focused on discovering and developing novel
drugs to treat cancer and inborn errors of metabolism, or IEMs, which
are rare genetic metabolic diseases, through scientific leadership in
the field of cellular metabolism. In addition to an active research and
discovery pipeline across both therapeutic areas, Agios has multiple
first-in-class lead product candidates in cancer metabolism and IEMs in
clinical and/or preclinical development. All Agios programs focus on
genetically identified patient populations, leveraging our knowledge of
metabolism, biology and genomics. For more information, please visit our
website at www.agios.com.
Source: Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals
Glenn Goddard, SVP Finance, investors@agios.com
or
Media
Contact:
Dan Budwick, 973-271-6085
dan@purecommunicationsinc.com
